SUSMED,Inc.
4263
Rank in Stocks
#25035
SUSMED,Inc. develops and sells therapeutic applications in Japan. It operates... SUSMED,Inc. develops and sells therapeutic applications in Japan. It operates through DTx product business, and DTx platform business segments. The company develops smartphone based digital therapeutics applications for diseases with insomnia, breast cancer, and kidney disease. It also develops and sells development platform for therapeutic apps and clinical trial systems. In addition, the company offers medical data analysis and consulting services. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.
Share Price
$1.70
Last synced: 2026-11-10
Market Cap
$28.75M
Change (1 day)
1.90%
Change (1 year)
-69.93%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade SUSMED,Inc. (4263)
Category
Healthcare
Operating Margin for SUSMED,Inc. (4263)
Operating Margin as of November 2026 TTM: -66.40%
According to SUSMED,Inc.'s latest financial reports, its current operating margin (TTM) is -66.40%. At the end of 2025 the company had an operating margin of -64.68%.
Operating Margin history for SUSMED,Inc. from 2020 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -66.40% | 2.66% |
| 2025 | -64.68% | -39.29% |
| 2024 | -106.54% | 1,070.77% |
| 2023 | -9.10% | -87.42% |
| 2022 | -72.32% | -74.95% |
| 2021 | -288.70% | -37.33% |
| 2020 | -460.70% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.58% |
US
|
|
| -149.01% | -97.76% |
US
|
|
| 25.57% | -100.39% |
AU
|
|
| 31.23% | -100.47% |
BE
|
|
| 29.35% | -100.44% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about SUSMED,Inc.'s operating margin
What is SUSMED,Inc.'s operating margin?
SUSMED,Inc.'s operating margin is -66.40%, as of Nov 2026.
What was SUSMED,Inc.'s operating margin in 2025?
In 2025, SUSMED,Inc.'s operating margin was -64.68%, compared with -106.54% in 2024.
How has SUSMED,Inc.'s operating margin changed since 2020?
From 2020 to 2025, SUSMED,Inc.'s operating margin was highest in 2023 (-9.10%) and lowest in 2020 (-460.70%).
How does SUSMED,Inc.'s operating margin compare with similar companies?
SUSMED,Inc.'s operating margin (-66.40%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.